# AVADEL PHARMACEUTICALS PLC (AVDL)

> Institutional ownership reported to the SEC as of Q1 2026, from Form 13F filings. Source: https://holderbook.com/stocks/AVDL/

- Reporting holders: 1
- Reported value: $426
- Held through calls: 0.0%
- Held through puts: 0.0%

A 13F reports long US equity positions only. Shorts, bonds, foreign listings and cash are not visible here, and positions are disclosed up to 45 days after the quarter ends.

## Largest holders

| Manager | Value | Shares | Share of their book | Quarters held |
|---|---|---|---|---|
| [IFP Advisors, Inc](https://holderbook.com/funds/1641866-ifp-advisors-inc/) | $426 | 20 | 0.0% | 6 |

## Quarter by quarter

| Quarter | Holders | Reported value |
|---|---|---|
| Q1 2026 | 1 | $426 |
| Q4 2025 | 209 | $1.7B |
| Q3 2025 | 189 | $1.3B |
| Q2 2025 | 170 | $723.1M |
| Q1 2025 | 176 | $2.4B |
| Q4 2024 | 161 | $867.4M |
| Q3 2024 | 180 | $1.1B |
| Q2 2024 | 147 | $984.4M |
| Q1 2024 | 7 | $36.6M |
| Q1 2023 | 1 | $4.3K |